375 related articles for article (PubMed ID: 16531561)
1. Systemic suppression of interferon-gamma responses in Buruli ulcer patients resolves after surgical excision of the lesions caused by the extracellular pathogen Mycobacterium ulcerans.
Yeboah-Manu D; Peduzzi E; Mensah-Quainoo E; Asante-Poku A; Ofori-Adjei D; Pluschke G; Daubenberger CA
J Leukoc Biol; 2006 Jun; 79(6):1150-6. PubMed ID: 16531561
[TBL] [Abstract][Full Text] [Related]
2. Immune response to infection with Mycobacterium ulcerans.
Gooding TM; Johnson PD; Campbell DE; Hayman JA; Hartland EL; Kemp AS; Robins-Browne RM
Infect Immun; 2001 Mar; 69(3):1704-7. PubMed ID: 11179346
[TBL] [Abstract][Full Text] [Related]
3. Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana.
Westenbrink BD; Stienstra Y; Huitema MG; Thompson WA; Klutse EO; Ampadu EO; Boezen HM; Limburg PC; van der Werf TS
Clin Diagn Lab Immunol; 2005 Jan; 12(1):125-9. PubMed ID: 15642996
[TBL] [Abstract][Full Text] [Related]
4. Buruli ulcer (Mycobacterium ulcerans infection).
Walsh DS; Portaels F; Meyers WM
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
6. Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.
Phillips R; Horsfield C; Kuijper S; Sarfo SF; Obeng-Baah J; Etuaful S; Nyamekye B; Awuah P; Nyarko KM; Osei-Sarpong F; Lucas S; Kolk AH; Wansbrough-Jones M
Clin Vaccine Immunol; 2006 Feb; 13(2):253-7. PubMed ID: 16467334
[TBL] [Abstract][Full Text] [Related]
7. Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.
Prévot G; Bourreau E; Pascalis H; Pradinaud R; Tanghe A; Huygen K; Launois P
Infect Immun; 2004 Feb; 72(2):958-65. PubMed ID: 14742541
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
Torrado E; Fraga AG; Logarinho E; Martins TG; Carmona JA; Gama JB; Carvalho MA; Proença F; Castro AG; Pedrosa J
J Immunol; 2010 Jan; 184(2):947-55. PubMed ID: 20008288
[TBL] [Abstract][Full Text] [Related]
9. Buruli ulcer and schistosomiasis: no association found.
Stienstra Y; van der Werf TS; van der Graaf WT; Secor WE; Kihlstrom SL; Dobos KM; Asamoa K; Quarshi E; Etuaful SN; Klutse EY; King CH
Am J Trop Med Hyg; 2004 Sep; 71(3):318-21. PubMed ID: 15381813
[TBL] [Abstract][Full Text] [Related]
10. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
[TBL] [Abstract][Full Text] [Related]
11. The level of PPD-specific IFN-gamma-producing CD4+ T cells in the blood predicts the in vivo response to PPD.
Martins MV; Lima MC; Duppre NC; Matos HJ; Spencer JS; Brennan PJ; Sarno EN; Fonseca L; Pereira GM; Pessolani MC
Tuberculosis (Edinb); 2007 May; 87(3):202-11. PubMed ID: 17049309
[TBL] [Abstract][Full Text] [Related]
12. [The contribution of skin autograft in open air in the treatment of the Buruli ulcer].
Kibadi Kapay A; Mputu-Yamba JB; Muyembe T; Bonga G; N'Siala A
Bull Soc Pathol Exot; 2005 Apr; 98(1):21-5. PubMed ID: 15915968
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.
Raghunathan PL; Whitney EA; Asamoa K; Stienstra Y; Taylor TH; Amofah GK; Ofori-Adjei D; Dobos K; Guarner J; Martin S; Pathak S; Klutse E; Etuaful S; van der Graaf WT; van der Werf TS; King CH; Tappero JW; Ashford DA
Clin Infect Dis; 2005 May; 40(10):1445-53. PubMed ID: 15844067
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium ulcerans infection (Buruli ulcer): a case report of the disseminated nonulcerative form.
Abalos FM; Aguiar J; Guédénon A; Portaels F; Meyers WM
Ann Diagn Pathol; 2000 Dec; 4(6):386-90. PubMed ID: 11149971
[TBL] [Abstract][Full Text] [Related]
17. Buruli ulcer: the third most common mycobacterial infection.
Weir E
CMAJ; 2002 Jun; 166(13):1691. PubMed ID: 12126327
[No Abstract] [Full Text] [Related]
18. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast].
van der Graaf WT; Scherpbier RW; van der Werf TS
Ned Tijdschr Geneeskd; 1999 Feb; 143(6):312-6. PubMed ID: 10221089
[TBL] [Abstract][Full Text] [Related]
19. Post-surgical assessment of excised tissue from patients with Buruli ulcer disease: progression of infection in macroscopically healthy tissue.
Bretzel G; Siegmund V; Racz P; van Vloten F; Ngos F; Thompson W; Biason P; Adjei O; Fleischer B; Nitschke J
Trop Med Int Health; 2005 Nov; 10(11):1199-206. PubMed ID: 16262747
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.
Gooding TM; Johnson PD; Smith M; Kemp AS; Robins-Browne RM
Infect Immun; 2002 Oct; 70(10):5562-7. PubMed ID: 12228283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
